On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Oklahoma State University Oklahoma City

InstitutionResearch output, impact & collaborations

Oklahoma State University Oklahoma City is a institution indexed in ScholarIQ from OpenAlex.

What is known about Oklahoma State University Oklahoma City?

ScholarIQrecord summary

Oklahoma State University Oklahoma City is a research organisation in Oklahoma City, US. OpenAlex records 18,271 works and 438,822 citations for it. 3,862 researchers list it as their most recent affiliation.

How many works does Oklahoma State University Oklahoma City have?

ScholarIQindexed works

Oklahoma State University Oklahoma City has 18,271 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Oklahoma State University Oklahoma City have?

ScholarIQcitation count

Oklahoma State University Oklahoma City has 438,822 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Oklahoma State University Oklahoma City?

ScholarIQresearcher count

Oklahoma State University Oklahoma City has 3,862 researchers in the ScholarIQ index.

What is the average h-index at Oklahoma State University Oklahoma City?

ScholarIQavg h-index

Oklahoma State University Oklahoma City has an average h-index of 73.4 in OpenAlex.

What is the ROR of Oklahoma State University Oklahoma City?

ScholarIQror

The ROR for Oklahoma State University Oklahoma City is on the source record.

What is the OpenAlex record for Oklahoma State University Oklahoma City?

ScholarIQopenalex

The OpenAlex for Oklahoma State University Oklahoma City is on the source record.

Who are the most-cited researchers behind Oklahoma State University Oklahoma City?

ScholarIQtop researchers by citations
1
Robert S. Mannel · Ovarian cancer diagnosis and treatment
391 works51,813 citations
2
G. A. Stewart · Particle physics theoretical and experimental studies
341 works36,847 citations
3
William Jones · Crystallization and Solubility Studies
957 works31,337 citations
4
G. A. Stewart · Particle physics theoretical and experimental studies
282 works22,407 citations
5
A. Khanov · Particle physics theoretical and experimental studies
311 works20,129 citations

What are the most-cited papers on Oklahoma State University Oklahoma City?

ScholarIQmost cited works
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang
New England Journal of Medicine. 20112,398 CitationsOPEN ACCESS
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke‐Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca N. Baergen
Journal of Clinical Oncology. 20032,059 Citations
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M. Norquist, Maria I. Harrell, Mark F. Brady, Tom Walsh, Ming K. Lee, Süleyman Gülsüner, Sarah S. Bernards, Silvia Casadei, Yi Qian, Robert A. Burger, John K. Chan, Susan A. Davidson, Robert S. Mannel, Paul DiSilvestro, Heather A. Lankes, Nilsa C. Ramirez, Mary‐Claire King, Elizabeth M. Swisher, Michael J. Birrer
JAMA Oncology. 2015771 CitationsOPEN ACCESS
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily Hinchcliff, Shashikant Lele, Lisa M. Landrum, Floor Backes, Roisin E. O’Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian
New England Journal of Medicine. 2023733 CitationsOPEN ACCESS
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Robert L. Coleman, Mark F. Brady, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong, Joan L. Walker, Byoung‐Gie Kim, Keiichi Fujiwara, Krishnansu S. Tewari, David M. O’Malley, Susan A. Davidson, Stephen C. Rubin, Paul DiSilvestro, Karen Basen‐Engquist, Helen Huang, John K. Chan, Nick M. Spirtos, Raheela Ashfaq, Robert S. Mannel
The Lancet Oncology. 2017608 CitationsOPEN ACCESS

How much of the research on Oklahoma State University Oklahoma City is open access?

ScholarIQopen access share
83%OPEN ACCESS
Gold
0%
Green
50%
Hybrid
0%
Bronze
33%
Closed
17%

Related on ScholarIQ

470M+ articles · 14-day free trial